The Generalist · 15 April 2025 · 1 h 27 min
Listen at the source: Mario Gabriele ↗ · audio
Josh Wolfe is a co-founder of Lux Capital, where he funds the kinds of ventures that change everything: think gene-edited pig organs and technology that lets you “record” smells. His approach? Relentless curiosity. He reads dozens of newspapers daily to identify patterns, always staying a few steps ahead. In this episode of The Generalist, Josh shares how his firm backs companies that don’t just predict the future, but create it. In our conversation, we explore: • The revolutionary development of genetically modified pig organs being transplanted into humans and what this means for the future of organ transplantation. • The recent achievement of "teleporting smell" across space and why computers that can replicate scents will open up entirely new industries. • Why Lux is investing in the search for real-life "X-Men" — genetic outliers in isolated populations whose DNA could lead to life-saving medical advancements. • How Josh evaluates macro trends to make smarter micro investment decisions and why ignoring the big picture is a mistake. • The three tech sectors that Josh believes will define the geopolitical balance in the decades ahead. • How Josh stays current on macroeconomic trends. • Much more — Thank you to the partners who make this possible Brex : The banking solution for startups. WorkOS : The modern identity platform for B2B SaaS. Generalist+ : Essential intelligence for modern investors and technologists.
As published with the episode at The Generalist ↗
No summary of this episode yet.